Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

News und Analysen

Cintas or UniFirst: Investors Win Either Way: https://www.marketbeat.com/logos/articles/med_20240327104510_chart-unf-ctas-3272024ver001.png
Cintas or UniFirst: Investors Win Either Way

Resilient labor markets, foresightful management, and capital returns drive long-term gains for investors in Cintas (NASDAQ: CTAS) and UniFirst (NYSE: UNF); the only question is which is the

Cintas or UniFirst: Investors Win Either Way: https://www.marketbeat.com/logos/articles/med_20240327104510_chart-unf-ctas-3272024ver001.png
Cintas or UniFirst: Investors Win Either Way

Resilient labor markets, foresightful management, and capital returns drive long-term gains for investors in Cintas (NASDAQ: CTAS) and UniFirst (NYSE: UNF); the only question is which is the

4 Stocks Building Long-Term Value for Shareholders: https://www.marketbeat.com/logos/articles/med_20240319091623_chart-unf-3192024ver001.png
4 Stocks Building Long-Term Value for Shareholders

Investing in business growth, acquisitions, improving margins, cash flow, dividends and share repurchases are among the leading drivers of shareholder value today. Oddly, too few companies rely on

4 Stocks Building Long-Term Value for Shareholders: https://www.marketbeat.com/logos/articles/med_20240319091623_chart-unf-3192024ver001.png
4 Stocks Building Long-Term Value for Shareholders

Investing in business growth, acquisitions, improving margins, cash flow, dividends and share repurchases are among the leading drivers of shareholder value today. Oddly, too few companies rely on

4 Stocks Building Long-Term Value for Shareholders: https://www.marketbeat.com/logos/articles/med_20240319091623_chart-unf-3192024ver001.png
4 Stocks Building Long-Term Value for Shareholders

Investing in business growth, acquisitions, improving margins, cash flow, dividends and share repurchases are among the leading drivers of shareholder value today. Oddly, too few companies rely on

JD.com Stock Is Back to 2018 Prices, Earnings Set to Beat Peers: https://www.marketbeat.com/logos/articles/med_20240305131907_jd.jpg
JD.com Stock Is Back to 2018 Prices, Earnings Set to Beat Peers

Investing in value opportunities usually comes with a feeling that you are going against the consensus, where everyone else will misunderstand your reasoning behind a potential investment and even

3 Reasons the Capital One-Discover merger is a big deal: https://www.marketbeat.com/logos/articles/med_20240221114956_3-reasons-the-capital-one-discover-merger-is-a-big.jpg
3 Reasons the Capital One-Discover merger is a big deal

What’s in your wallet? In the not-so-distant future, it might be a card issued by the combined entity of Capital One Financial Corp. (NYSE: COF) and Discover Financial Services (NYSE: DFS)

Intuitive Surgical’s post-earnings dip is a healthy time to buy: https://www.marketbeat.com/logos/articles/med_20240124145004_chart-isrg-1242024ver001.png
Intuitive Surgical’s post-earnings dip is a healthy time to buy

Intuitive Surgical (NASDAQ: ISRG) share prices surged following the Q4 release but failed to hold the gain, creating an ugly candle capping a strong rally. The market may move lower from here, but

Intuitive Surgical’s post-earnings dip is a healthy time to buy: https://www.marketbeat.com/logos/articles/med_20240124145004_chart-isrg-1242024ver001.png
Intuitive Surgical’s post-earnings dip is a healthy time to buy

Intuitive Surgical (NASDAQ: ISRG) share prices surged following the Q4 release but failed to hold the gain, creating an ugly candle capping a strong rally. The market may move lower from here, but

MarketBeat ‘Stock of the Week’: Intuitive Surgical hits new highs: https://www.marketbeat.com/logos/articles/med_20240122061820_marketbeat-stock-of-the-week-intuitive-surgical-hi.png
MarketBeat ‘Stock of the Week’: Intuitive Surgical hits new highs

In the fall of 2023, Intuitive Surgical, Inc. (NASDAQ: ISRG) was among a group of health care provider and food manufacturer stocks crushed by Ozempic fears. The prevailing mindset was that rising

MarketBeat ‘Stock of the Week’: Intuitive Surgical hits new highs: https://www.marketbeat.com/logos/articles/med_20240122061820_marketbeat-stock-of-the-week-intuitive-surgical-hi.png
MarketBeat ‘Stock of the Week’: Intuitive Surgical hits new highs

In the fall of 2023, Intuitive Surgical, Inc. (NASDAQ: ISRG) was among a group of health care provider and food manufacturer stocks crushed by Ozempic fears. The prevailing mindset was that rising

3 high yield stock ETFs that make any income portfolio better: https://www.marketbeat.com/logos/articles/med_20240117070534_3-high-yield-stock-etfs-that-make-any-income-portf.jpg
3 high yield stock ETFs that make any income portfolio better

When preparing a winning meal, careful selection of the right ingredients is paramount. The same can be said about building a winning investment portfolio.

Once a money-making strategy has been

UniFirst stock falls into the buy zone: https://www.marketbeat.com/logos/articles/med_20240103094647_chart-unf-132023ver001.png
UniFirst stock falls into the buy zone

UniFirst (NYSE: UNF) had a decent first quarter but provided weak guidance, sending shares down nearly 10%. As bad as the move sounds, it’s a knee-jerk reaction in a stock whose future is bright

UniFirst stock falls into the buy zone: https://www.marketbeat.com/logos/articles/med_20240103094647_chart-unf-132023ver001.png
UniFirst stock falls into the buy zone

UniFirst (NYSE: UNF) had a decent first quarter but provided weak guidance, sending shares down nearly 10%. As bad as the move sounds, it’s a knee-jerk reaction in a stock whose future is bright

UniFirst stock falls into the buy zone: https://www.marketbeat.com/logos/articles/med_20240103094647_chart-unf-132023ver001.png
UniFirst stock falls into the buy zone

UniFirst (NYSE: UNF) had a decent first quarter but provided weak guidance, sending shares down nearly 10%. As bad as the move sounds, it’s a knee-jerk reaction in a stock whose future is bright

Ray Dalio keeps adding to this ETF, what's he thinking?: https://www.marketbeat.com/logos/articles/med_20231228072323_ray-dalio-keeps-adding-to-this-etf-whats-he-thinki.jpg
Ray Dalio keeps adding to this ETF, what's he thinking?

Last quarter, it became evident to thousands of investors just like you just how bullish Ray Dalio had become on Asian markets. Still, while most thought it was a one-time allocation to gain the

XLF's stellar year-end run: key insights & top performers: https://www.marketbeat.com/logos/articles/med_20231226070512_xlfs-stellar-year-end-run-key-insights-top-perform.jpg
XLF's stellar year-end run: key insights & top performers

The financial sector and popular sector ETF Financial Select Sector Fund (NYSE: XLF) has enjoyed a stellar end to the year. A quick glance at the XLF’s daily chart almost makes it appear like the

XLF's stellar year-end run: key insights & top performers: https://www.marketbeat.com/logos/articles/med_20231226070512_xlfs-stellar-year-end-run-key-insights-top-perform.jpg
XLF's stellar year-end run: key insights & top performers

The financial sector and popular sector ETF Financial Select Sector Fund (NYSE: XLF) has enjoyed a stellar end to the year. A quick glance at the XLF’s daily chart almost makes it appear like the

C4 Therapeutics blasts off: what's next?: https://www.marketbeat.com/logos/articles/med_20231218075311_c4-therapeutics-blasts-off-whats-next.jpg
C4 Therapeutics blasts off: what's next?

As the market soars to new heights, with capital fast flowing back into the small-cap, more speculative, and traditionally risky investments and sectors, C4 Therapeutics (NASDAQ: CCCC) has become

At a $122.25 price target, PDD analysts need to catch up: https://www.marketbeat.com/logos/articles/med_20231129084845_at-a-122.jpg
At a $122.25 price target, PDD analysts need to catch up

Shares of PDD Holdings (NASDAQ: PDD) rallied by 18.1% during Tuesday's trading session. What is the reason? A higher-than-expected quarterly earnings report. Now, you could have seen this coming

3 payroll companies get clocked, but 1 looks cheap: https://www.marketbeat.com/logos/articles/med_20231105150724_chart-payc.jpg
3 payroll companies get clocked, but 1 looks cheap

Payroll companies alleviate the complexities of processing payrolls. They withhold taxes, apply payments to various government agencies, track employee hours, track benefits, comply with

3 payroll companies get clocked, but 1 looks cheap: https://www.marketbeat.com/logos/articles/med_20231105150724_chart-payc.jpg
3 payroll companies get clocked, but 1 looks cheap

Payroll companies alleviate the complexities of processing payrolls. They withhold taxes, apply payments to various government agencies, track employee hours, track benefits, comply with

3 payroll companies get clocked, but 1 looks cheap: https://www.marketbeat.com/logos/articles/med_20231105150724_chart-payc.jpg
3 payroll companies get clocked, but 1 looks cheap

Payroll companies alleviate the complexities of processing payrolls. They withhold taxes, apply payments to various government agencies, track employee hours, track benefits, comply with

Cintas: A Quality Buy and Hold Forever Stock at Any Price: https://www.marketbeat.com/logos/articles/med_20230926091501_chart-ctas-9262023ver001.png
Cintas: A Quality Buy and Hold Forever Stock at Any Price

If there is one thing true about Cintas (NASDAQ: CTAS), the company delivers results. It has delivered results quarter after quarter, year after year, for more than 2 decades, and it will continue

Cintas: A Quality Buy and Hold Forever Stock at Any Price: https://www.marketbeat.com/logos/articles/med_20230926091501_chart-ctas-9262023ver001.png
Cintas: A Quality Buy and Hold Forever Stock at Any Price

If there is one thing true about Cintas (NASDAQ: CTAS), the company delivers results. It has delivered results quarter after quarter, year after year, for more than 2 decades, and it will continue